|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-03
|
$704,248
|
$704,248
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Yale SPORE in Skin Cancer
|
4P50CA121974-10
|
$2,161,999
|
$259,440
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
3P50CA196530-02S1
|
$715,091
|
$250,282
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-02
|
$2,161,996
|
$756,699
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$24,310
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$12,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$25,125
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$40,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$96,975
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$100,500
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$520,001
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$12,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$428,154
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
1P50CA196510-01A1
|
$2,186,724
|
$174,938
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
|
4R01CA161048-05
|
$345,488
|
$345,488
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-02
|
$332,363
|
$332,363
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont PROSPR Research Center (VPRC)
|
3U54CA163303-05S2
|
$60,149
|
$3,007
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
5U01CA196383-02
|
$63,612
|
$31,806
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF Signaling in Mammary Tumorigenesis
|
4R01CA168464-05
|
$347,563
|
$173,782
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Vascular mechanisms regulating breast cancer brain metastasis
|
4R01CA170140-05
|
$357,419
|
$357,419
|
ELICEIRI, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-03
|
$321,625
|
$321,625
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,126,266
|
$337,880
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
1F31CA210467-01
|
$38,128
|
$38,128
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Validation of, and therapeutic evaluation in ovarian cancer GEM models
|
ZIA BC 011737
|
$339,411
|
$84,853
|
Sharan, Shyam
|
CCR (NCI)
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
5R01CA195493-02
|
$257,699
|
$51,540
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
1UH2CA206124-01
|
$211,875
|
$211,875
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
1U01CA200466-01
|
$902,819
|
$451,410
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-01S1
|
$171,812
|
$85,906
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
4P01CA154291-05
|
$2,641,256
|
$554,664
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$18,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$643,274
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using the Collaborative Cross for Model Studies of Intestinal Cancer
|
1R21CA202496-01A1
|
$203,580
|
$50,895
|
SIRACUSA, LINDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
|
1R21CA201865-01A1
|
$215,325
|
$215,325
|
LIANG, GANGNING
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$24,782
|
$17,347
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$1,080,332
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$10,200
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$6,375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-14S1
|
$217,227
|
$73,857
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
4U54CA096297-14
|
$1,467,170
|
$498,838
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
1R01CA184804-01A1
|
$387,731
|
$387,731
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-02
|
$436,922
|
$218,461
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
1R21CA208609-01
|
$203,580
|
$203,580
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S6
|
$12,771
|
$383
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S1
|
$113,625
|
$3,409
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S2
|
$246,024
|
$7,381
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S3
|
$123,494
|
$3,705
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S4
|
$163,814
|
$4,914
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-12
|
$2,246,011
|
$67,380
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$33,737
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$84,885
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
Total relevant funding to Metastasis for this search: $409,622,279
|